Cardiora Pty Ltd.
5Patents
4Active
5Granted
40Portfolio score
Filing activity: Aug 16, 2012 → Nov 20, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10493067B2 | Method of treating heart failure with preserved ejection fraction by administering milrinone | Human Necessities | 1 | Active |
| US10537527B2 | Milrinone controlled-release formulation | General | 0 | Revoked |
| US10736853B2 | Milrinone controlled-release formulation | Human Necessities | 0 | Active |
| US10137093B2 | Milrinone controlled-release formulation | Human Necessities | 0 | Active |
| US10517833B2 | Uses of milrinone controlled-release formulation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.